# Round 4 — Rebuttal (same packet, panel disagreements only)

You previously reviewed the CTV biocontainment verification packet as one seat on a 6-model
panel. All six reviews are in. Below are ONLY the claims where your verdict diverged from the
panel plurality, plus the strongest opposing argument(s) another seat produced — including
recomputations from primary sources and from the project's own sequence files.

For each claim respond in exactly this format:

**N — HOLD** <your verdict> — why the opposing argument fails (one to three lines), or
**N — CONCEDE** to <C/X/?> — what changed your mind.

Rules: no new claims; no re-litigating claims not listed; cite evidence, not vibes; if the
opposing recomputation is checkable and right, concede cleanly. End with:

**REVISED core-decision score: X/10** — one line on what moved it (or "unchanged").

Legend: C=confirm, X=challenge, ?=flag-unknown. "Cl(Fable)" verdicts come from recomputation
against the project's own GenBank files and the Harper 2016 PDF, both on disk in this repo.

---
## Your verdict: GPT-6-astra (10 C / 16 X / 19 ?, score 2/10) — panel outlier

You are the only seat under 7/10. Some of your challenges are real catches the panel adopts; others fail against direct recomputation. Sorted:

### Panel credits you (no response needed)
- **41** boundary overlap at 5%/15% — unique catch, adopted by all.
- **43** side: power claims underspecified without baseline/sidedness — plurality agrees.

### Where direct recomputation opposes you (respond HOLD/CONCEDE)
**9 — You: X.** 95/215 = 44.186% rounds to 44.19%; packet wrote 44.18%. DeepSeek flagged the same and still CONFIRMED (trivial rounding). HOLD or concede triviality?

**23 — You: X.** Fable recomputed from raw counts in exact arithmetic: additive null 5.386%, observed excess 12.47 pp, pair/WT = 74.06%; binomial P(X≥35 | n=196, p=0.053) ≈ 3×10⁻¹⁰; Bliss/multiplicative null 5.8% — scale-independent. So the synergy is not "merely descriptive": it is ~10ᵗʰ-order significant on any standard scale. HOLD or concede the magnitude/robustness?

**24 — You: X. Panel: X ×2 more (Grok, DeepSeek), C ×2 (Fable, Gemini).** Plurality position: operational conclusion stands ("move both genes"), word "falsified" does not; reciprocal-direction inference acknowledged. Converge there?

**25 — You: X (control identity: 1/66 field vs clone baseline).** Fable: on either baseline the contrast is decisive — vs 1/172 clone baseline Fisher p ≈ 3×10⁻⁴, vs 1/66 p = 0.00116; OR = 14.05. The identity-slip note is valid documentation hygiene; it does not threaten the claim. HOLD?

**31 — You: X.** Your point is that "neither sufficient nor explanatory" conflates two claims. All five other seats confirmed. Is your challenge phrasing-only (then converge), or do you dispute the 15×-apart R174 data?

**33 — You: X.** Fable re-derived from the repo's own GenBank files: claim 30 is *false* (T68-1 = R174), but the conclusion route re-anchors on claim 31 + Harper's own K174-retaining hybrids (35/196, 52/253). "Residue story dead, gene-level result survives" then holds on *verified* data. Your "premature" objection predates that evidence — update?

**38 — You: X.** The claim is a *non-claim* ("we do not claim a precedent exists"). Requiring a systematic review to support an absence-of-claim inverts the burden. HOLD?

### Your 19 flag-unknowns
Panel norms: T2/T3/T4 tiers honestly label verification depth; flagging every paper you personally can't fetch is not a challenge to the packet. No per-item action — but consider whether your 2/10 double-counted inaccessibility as error. Other seats with the same access limits scored 7–9.
